MS drugs scheme a ‘costly failure’ that set back NHS £250m
Jun 4th, 2010 | Filed under DailyMail
Jump to related media:
Add to My Stories MS is a disease of the central nervous system. MRI brain scans show up lesions, which are inflamed areas A risk-sharing scheme to supply multiple sclerosis (MS) medicines to patients has been a ‘costly failure’, experts have said. The NHS could have saved £250million if the scheme had been properly assessed after two years they said, adding that the money could have been better spent on other treatments
Go here to see the original:
DailyMail
Leave a comment | Trackback